Top Markets
Coin of the day
Medigen Biotechnology Corp. Medigen Biotechnology Corp.

Medigen Biotechnology Corp.

3176
Classifica tra le azioni #19063
Medigen Biotechnology Corp. is a Taiwanese biopharmaceutical company dedicated... Medigen Biotechnology Corp. is a Taiwanese biopharmaceutical company dedicated to inventing therapies for liver diseases and various forms of cancer. Its product portfolio includes advanced cell therapies like MAGICELL-NK, which leverages natural killer cells, and MAGICELL-GDT, a T-cell-based treatment. A significant pipeline asset for Medigen is OBP-301. This therapeutic has completed Phase I clinical trials for combination therapy in esophageal cancer in Japan. It is currently being evaluated in ongoing Phase I trials in Japan, combining it with immune checkpoint inhibitors (ICIs) for esophageal cancer, and has advanced to Phase II studies in the United States, investigating its use with ICIs for both esophageal and gastric cancer. Established in 1999, Medigen Biotechnology Corp. maintains its corporate headquarters in Taipei, Taiwan.
Prezzo delle azioni
$1.27
Capitalizzazione di mercato
$176.31M
Variazione (1 giorno)
5.57%
Variazione (1 anno)
29.36%
Paese
TW
Scambia Medigen Biotechnology Corp. (3176)

Categoria

Storico del prezzo dell'azione per Medigen Biotechnology Corp. (3176)
Prezzo di chiusura più alto: $1.12 il 2026-08-01

Prezzo di chiusura più basso: $1.26 il 2007-12-01
Storico del prezzo dell'azione di Medigen Biotechnology Corp. dal 2007 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) 0.89%
2025 -0.53%
2024 -32.95%
2023 27.93%
2022 -41.27%
2021 -4.41%
2020 1.18%
2019 52.77%
2018 15.52%
2017 -52.31%
2016 -10.15%
2015 -44.93%
2014 -20.99%
2013 7.34%
2012 409.30%
2011 131.95%
2010 8.02%
2009 42.20%
2008 -74.41%
2007 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$553.09 42.85%
US
$1.02K 44.02%
NL
$158.64 541.49%
US
$121.62 -12.98%
AU
$769.41 6.94%
CH